Literature DB >> 2959695

Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders.

H M van Praag1, R S Kahn, G M Asnis, S Wetzler, S L Brown, A Bleich, M L Korn.   

Abstract

5-Hydroxytryptamine (5-HT) disorders have been reported to occur in a variety of psychiatric disorders. The situation has been called chaotic, the disturbances non-specific. We reject this viewpoint. 5-HT disturbances are non-specific only from a nosological/categorical viewpoint; they seem rather specific from a functional/dimensional point of view, correlating as they do with particular psychopathological dimensions, i.e. aggression-, anxiety- and possibly mood-disregulation, across diagnosis. The evolution of 5-HT research in psychiatry illustrates the importance of what we have called the functional approach, implying dissection of a given psychopathological syndrome in its component parts, i.e., the psychological dysfunctions, and searching for correlations between biological and psychological dysfunctions. The rigid preoccupation of biological psychiatry with the search for markers of disease entities has hampered progress. The functional approach should be incorporated in biological psychiatry, not as an alternative for the nosological approach but as its complement.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2959695     DOI: 10.1016/0165-0327(87)90067-x

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  27 in total

1.  Biological psychiatry: still marching forward in a dead end.

Authors:  Herman M VAN Praag
Journal:  World Psychiatry       Date:  2010-10       Impact factor: 49.548

Review 2.  [Is delusion a reasonable scientific term? Reflections on psychopathology in the psychiatry of the twenty-first century].

Authors:  P Hoff
Journal:  Nervenarzt       Date:  2016-01       Impact factor: 1.214

Review 3.  The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention.

Authors:  Maurizio Pompili; Gianluca Serafini; Marco Innamorati; Anne Maria Möller-Leimkühler; Giancarlo Giupponi; Paolo Girardi; Roberto Tatarelli; David Lester
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02-20       Impact factor: 5.270

Review 4.  The dimensional approach to clinical psychopharmacology: a polysemous concept.

Authors:  P Baruch; M J Filteau; R H Bouchard; E Pourcher; P Vincent; R Jouvent
Journal:  J Psychiatry Neurosci       Date:  1992-06       Impact factor: 6.186

5.  A controlled study of Tourette syndrome-Revisited: A reply to the letter of Pauls et al.

Authors:  D E Comings; B G Comings
Journal:  Am J Hum Genet       Date:  1988-08       Impact factor: 11.025

Review 6.  Current perspectives on the genetics of unipolar depression.

Authors:  S O Moldin; T Reich; J P Rice
Journal:  Behav Genet       Date:  1991-05       Impact factor: 2.805

7.  Depressed suicidal adolescent males have an altered cortisol response to a pharmacological challenge.

Authors:  Neera Ghaziuddin; Cheryl A King; Kathleen Welch; Mohammad Ghaziuddin
Journal:  Asian J Psychiatr       Date:  2013-10-12

Review 8.  Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence.

Authors:  M Virkkunen; D Goldman; D A Nielsen; M Linnoila
Journal:  J Psychiatry Neurosci       Date:  1995-07       Impact factor: 6.186

9.  Reduction in suicidal ideation with SSRIs: a review of 459 depressed patients.

Authors:  M J Filteau; Y D Lapierre; D Bakish; A Blanchard
Journal:  J Psychiatry Neurosci       Date:  1993-05       Impact factor: 6.186

Review 10.  Future antidepressants: what is in the pipeline and what is missing?

Authors:  Fokko J Bosker; Ben H C Westerink; Thomas I F H Cremers; Marjolein Gerrits; Marieke G C van der Hart; Sjoukje D Kuipers; Gieta van der Pompe; Gert J ter Horst; Johan A den Boer; Jakob Korf
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.